415 related articles for article (PubMed ID: 31271898)
41. Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines.
Li Z; Li Q; Han L; Tian N; Liang Q; Li Y; Zhao X; Du C; Tian Y
Oncol Rep; 2016 Feb; 35(2):1013-9. PubMed ID: 26718027
[TBL] [Abstract][Full Text] [Related]
42. Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-alpha chain.
Karras JG; Maier MA; Lu T; Watt A; Manoharan M
Biochemistry; 2001 Jul; 40(26):7853-9. PubMed ID: 11425312
[TBL] [Abstract][Full Text] [Related]
43. Roles and mechanisms of alternative splicing in cancer - implications for care.
Bonnal SC; López-Oreja I; Valcárcel J
Nat Rev Clin Oncol; 2020 Aug; 17(8):457-474. PubMed ID: 32303702
[TBL] [Abstract][Full Text] [Related]
44. Modified U1 snRNA and antisense oligonucleotides rescue splice mutations in SLC26A4 that cause hereditary hearing loss.
Lee B; Kim YR; Kim SJ; Goh SH; Kim JH; Oh SK; Baek JI; Kim UK; Lee KY
Hum Mutat; 2019 Aug; 40(8):1172-1180. PubMed ID: 31033086
[TBL] [Abstract][Full Text] [Related]
45. Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies.
Li D; McIntosh CS; Mastaglia FL; Wilton SD; Aung-Htut MT
Transl Neurodegener; 2021 May; 10(1):16. PubMed ID: 34016162
[TBL] [Abstract][Full Text] [Related]
46. Modulating the expression of disease genes with RNA-based therapy.
Wood M; Yin H; McClorey G
PLoS Genet; 2007 Jun; 3(6):e109. PubMed ID: 17604456
[TBL] [Abstract][Full Text] [Related]
47. The structure and function of proteins involved in mammalian pre-mRNA splicing.
Krämer A
Annu Rev Biochem; 1996; 65():367-409. PubMed ID: 8811184
[TBL] [Abstract][Full Text] [Related]
48. Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression.
Lim KH; Han Z; Jeon HY; Kach J; Jing E; Weyn-Vanhentenryck S; Downs M; Corrionero A; Oh R; Scharner J; Venkatesh A; Ji S; Liau G; Ticho B; Nash H; Aznarez I
Nat Commun; 2020 Jul; 11(1):3501. PubMed ID: 32647108
[TBL] [Abstract][Full Text] [Related]
49. Splicing in the pathogenesis, diagnosis and treatment of ciliopathies.
Wheway G; Lord J; Baralle D
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194433. PubMed ID: 31698098
[TBL] [Abstract][Full Text] [Related]
50. Sensitivity of splice sites to antisense oligonucleotides in vivo.
Sierakowska H; Sambade MJ; Schümperli D; Kole R
RNA; 1999 Mar; 5(3):369-77. PubMed ID: 10094306
[TBL] [Abstract][Full Text] [Related]
51. In Brief: (mis)splicing in disease.
Pedrotti S; Cooper TA
J Pathol; 2014 May; 233(1):1-3. PubMed ID: 24615176
[TBL] [Abstract][Full Text] [Related]
52. The mechanism of splicing as told by group II introns: Ancestors of the spliceosome.
Smathers CM; Robart AR
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194390. PubMed ID: 31202783
[TBL] [Abstract][Full Text] [Related]
53. Development and validation of AI/ML derived splice-switching oligonucleotides.
Fronk AD; Manzanares MA; Zheng P; Geier A; Anderson K; Stanton S; Zumrut H; Gera S; Munch R; Frederick V; Dhingra P; Arun G; Akerman M
Mol Syst Biol; 2024 Jun; 20(6):676-701. PubMed ID: 38664594
[TBL] [Abstract][Full Text] [Related]
54. Antisense-mediated redirection of mRNA splicing.
Vacek M; Sazani P; Kole R
Cell Mol Life Sci; 2003 May; 60(5):825-33. PubMed ID: 12827272
[TBL] [Abstract][Full Text] [Related]
55. Regulation of alternative mRNA splicing: old players and new perspectives.
Dvinge H
FEBS Lett; 2018 Sep; 592(17):2987-3006. PubMed ID: 29856907
[TBL] [Abstract][Full Text] [Related]
56. Splicing of pre-mRNA: mechanism, regulation and role in development.
Rio DC
Curr Opin Genet Dev; 1993 Aug; 3(4):574-84. PubMed ID: 8241769
[TBL] [Abstract][Full Text] [Related]
57. Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake.
Schmajuk G; Sierakowska H; Kole R
J Biol Chem; 1999 Jul; 274(31):21783-9. PubMed ID: 10419493
[TBL] [Abstract][Full Text] [Related]
58. Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.
Dominski Z; Kole R
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8673-7. PubMed ID: 8378346
[TBL] [Abstract][Full Text] [Related]
59. RNA Secondary Structure-Based Design of Antisense Peptide Nucleic Acids for Modulating Disease-Associated Aberrant Tau Pre-mRNA Alternative Splicing.
Ong AAL; Tan J; Bhadra M; Dezanet C; Patil KM; Chong MS; Kierzek R; Decout JL; Roca X; Chen G
Molecules; 2019 Aug; 24(16):. PubMed ID: 31434312
[TBL] [Abstract][Full Text] [Related]
60. Modulating splicing with small molecular inhibitors of the spliceosome.
Effenberger KA; Urabe VK; Jurica MS
Wiley Interdiscip Rev RNA; 2017 Mar; 8(2):. PubMed ID: 27440103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
